Germany suspends AstraZeneca vaccine amid clotting concerns
BERLIN (AP) – The German government says it is suspending use of AstraZeneca’s coronavirus vaccine over fresh reports of dangerous blood clots in connection with the shot.
The Health Ministry said Monday the decision was taken as a “precaution” and on the advice of Germany’s national vaccine regulator, the Paul Ehrlich Institute, which called for further investigation of the cases.
In a statement, the ministry said the European Medicines Agency would decide “whether and how the new information will affect the authorization of the vaccine.” In its statement, the health ministry said the reported blood clots involved cerebral veins, but didn’t specify where or when the incidents occurred.
EXPLAINER: Why countries are halting the AstraZeneca shot
LONDON (AP) – In recent days, countries including Denmark, Ireland, and Thailand have temporarily suspended their use of AstraZeneca’s coronavirus vaccine after reports that some people who got a dose developed blood clots, even though there’s no evidence that the shot was responsible.
The European Medicines Agency and the World Health Organization say the data available do not suggest the vaccine caused the clots and that people should continue to be immunized.
AstraZeneca said it had carefully reviewed the data on 17 million people who received doses across Europe. It said there was “no evidence of an increased risk” of blood clots in any age group or gender in any country.